Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 35.31% is 271% above its 5-year average of -20.68%, near the high end of its 5-year range (-36.20%–35.31%).
350.25% above its 12-month average of -14.11%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -0.15%.
RETURN ON ASSETS (ROA)
35.31%
RETURN ON ASSETS (ROA) AVG TTM
-14.11%
RETURN ON ASSETS (ROA) AVG 3Y
-23.46%
RETURN ON ASSETS (ROA) AVG 5Y
-20.68%
RETURN ON ASSETS (ROA) AVG 10Y
-27.43%
RETURN ON ASSETS (ROA) AVG 15Y
-33.04%
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+350.25%
CURRENT VS 3Y AVG
+250.51%
CURRENT VS 5Y AVG
+270.70%
CURRENT VS 10Y AVG
+228.73%
CURRENT VS 15Y AVG
+206.86%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.37%
median of 787 covered companies
CURRENT VS SECTOR MEDIAN
+212.56%
vs the sector median at left
Fortress Biotech, Inc.
Market Cap
$139.73M
Return on Assets (ROA)
35.31%
TTM Avg
-14.11%
3Y Avg
-23.46%
5Y Avg
-20.68%
Market Cap
$139.08M
Return on Assets (ROA)
-36.33%
TTM Avg
-27.39%
3Y Avg
-256.74%
5Y Avg
-207.88%
Market Cap
$137.57M
Return on Assets (ROA)
-6.51%
TTM Avg
-15.82%
3Y Avg
-25.09%
5Y Avg
-19.08%
Market Cap
$141.94M
Return on Assets (ROA)
-28.35%
TTM Avg
-69.97%
3Y Avg
-58.34%
5Y Avg
-49.63%
Market Cap
$142.47M
Return on Assets (ROA)
-92.89%
TTM Avg
-84.34%
3Y Avg
-55.16%
5Y Avg
-43.29%
Market Cap
$135.99M
Return on Assets (ROA)
-33.22%
TTM Avg
-27.55%
3Y Avg
-27.55%
5Y Avg
-27.55%
Market Cap
$135.09M
Return on Assets (ROA)
-6.07%
TTM Avg
-5.08%
3Y Avg
-4.92%
5Y Avg
-1.70%
Market Cap
$143.18M
Return on Assets (ROA)
-59.36%
TTM Avg
-56.73%
3Y Avg
-42.41%
5Y Avg
-32.43%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIOP) | $139.73M | 35.31% | -14.11% | -23.46% | -20.68% |
| Alpha Cognition Inc (ACOG)vs › | $139.08M | -36.33% | -27.39% | -256.74% | -207.88% |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.57M | -6.51% | -15.82% | -25.09% | -19.08% |
| Immuneering Corporation (IMRX)vs › | $141.94M | -28.35% | -69.97% | -58.34% | -49.63% |
| Sutro Biopharma, Inc. (STRO)vs › | $142.47M | -92.89% | -84.34% | -55.16% | -43.29% |
| Atrium Therapeutics, Inc. (RNA)vs › | $135.99M | -33.22% | -27.55% | -27.55% | -27.55% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $135.09M | -6.07% | -5.08% | -4.92% | -1.70% |
| Freenome, Inc. (FRNM)vs › | $135.31M | N/A | N/A | N/A | N/A |
| Nyxoah S.A. (NYXH)vs › | $143.18M | -59.36% | -56.73% | -42.41% | -32.43% |
| Korsana Biosciences, Inc. (KRSA)vs › | $144.23M | -96.78% | -33.63% | -87.61% | -84.15% |
ROA
35.3%
ROE
68.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 3.67% |
| 2024-12-31 | -31.89% |
| 2023-12-31 | -36.20% |
| 2022-12-31 | -29.42% |
| 2021-12-31 | -16.32% |
| 2020-12-31 | -13.95% |
| 2019-12-31 | -17.65% |
| 2018-12-31 | -59.68% |
| 2017-12-31 | -27.19% |
| 2016-12-31 | -32.27% |
| 2015-12-31 | -40.83% |
| 2014-12-31 | -22.82% |
| 2013-12-31 | -36.94% |
| 2012-12-31 | -67.35% |
| 2011-12-31 | -155.55% |
| 2010-12-31 | -66.82% |
| 2009-12-31 | -217.31% |
| 2008-12-31 | 0.00% |
